Summarization: Background/Aim: Mathematical models have long been considered as important tools in cancer biology and therapy. Herein, we present an advanced non-linear mathematical model that can predict accurately the effect of an anticancer agent on the growth of a solid tumor. Materials and Methods: Advanced non-linear mathematical optimization techniques and human-to-mouse experimental data were used to develop a tumor growth inhibition (TGI) estimation model. Results: Using this mathematical model, we could accurately predict the tumor mass in a human-to-mouse pancreatic ductal adenocarcinoma (PDAC) xenograft under gemcitabine treatment up to five time periods (points) ahead of the last treatment. Conclusion: The ability of the identi...
International audienceWith the aim of inhibiting cancer growth and reducing the risk of metastasis, ...
With the aim of inhibiting cancer growth and reducing the risk of metastasis, pharmaceutical compani...
With the aim of inhibiting cancer growth and reducing the risk of metastasis, pharmaceutical compani...
Summarization: Combination chemotherapy, i.e. multiple anticancer drugs given in combination, is a v...
A mathematical model for describing the cancer growth dynamics in response to anticancer agents adm...
More than eighty percent of pancreatic cancer involves ductal adenocarcinoma with an abundant desmop...
More than eighty percent of pancreatic cancer involves ductal adenocarcinoma with an abundant desmop...
International audienceWith the aim of inhibiting cancer growth and reducing the risk of metastasis, ...
With the aim of inhibiting cancer growth and reducing the risk of metastasis, pharmaceutical compani...
International audienceWith the aim of inhibiting cancer growth and reducing the risk of metastasis, ...
International audienceWith the aim of inhibiting cancer growth and reducing the risk of metastasis, ...
International audienceWith the aim of inhibiting cancer growth and reducing the risk of metastasis, ...
International audienceWith the aim of inhibiting cancer growth and reducing the risk of metastasis, ...
International audienceWith the aim of inhibiting cancer growth and reducing the risk of metastasis, ...
International audienceWith the aim of inhibiting cancer growth and reducing the risk of metastasis, ...
International audienceWith the aim of inhibiting cancer growth and reducing the risk of metastasis, ...
With the aim of inhibiting cancer growth and reducing the risk of metastasis, pharmaceutical compani...
With the aim of inhibiting cancer growth and reducing the risk of metastasis, pharmaceutical compani...
Summarization: Combination chemotherapy, i.e. multiple anticancer drugs given in combination, is a v...
A mathematical model for describing the cancer growth dynamics in response to anticancer agents adm...
More than eighty percent of pancreatic cancer involves ductal adenocarcinoma with an abundant desmop...
More than eighty percent of pancreatic cancer involves ductal adenocarcinoma with an abundant desmop...
International audienceWith the aim of inhibiting cancer growth and reducing the risk of metastasis, ...
With the aim of inhibiting cancer growth and reducing the risk of metastasis, pharmaceutical compani...
International audienceWith the aim of inhibiting cancer growth and reducing the risk of metastasis, ...
International audienceWith the aim of inhibiting cancer growth and reducing the risk of metastasis, ...
International audienceWith the aim of inhibiting cancer growth and reducing the risk of metastasis, ...
International audienceWith the aim of inhibiting cancer growth and reducing the risk of metastasis, ...
International audienceWith the aim of inhibiting cancer growth and reducing the risk of metastasis, ...
International audienceWith the aim of inhibiting cancer growth and reducing the risk of metastasis, ...
International audienceWith the aim of inhibiting cancer growth and reducing the risk of metastasis, ...
With the aim of inhibiting cancer growth and reducing the risk of metastasis, pharmaceutical compani...
With the aim of inhibiting cancer growth and reducing the risk of metastasis, pharmaceutical compani...